Sarepta’s LGMD Grant Award Program grew out of a community-identified need to address the slow and often frustrating path to an LGMD diagnosis. The global program supports innovative efforts to shorten the diagnostic journey, and in its inaugural year provided grants to patient advocacy organizations in India, South Africa, Canada and the United States. Watch to learn more about the program and hear from Diane Berry, PhD, Executive Vice President and Chief Global Policy & Advocacy Officer, on Sarepta’s commitment to supporting the LGMD community. The 2024 LGMD Grant Award Program is now open and accepting applications through July 19, 2024. Learn more about how patient advocacy organizations may apply: https://lnkd.in/eFMgnDqK.
Sarepta Therapeutics
Biotechnology Research
Cambridge, MA 103,705 followers
Dragging Tomorrow Into Today.
About us
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For information on our Community Guidelines, please visit sarepta.com/community-guidelines. We want to share a reminder with all job seekers and candidates regarding the persistence of recruiting fraud. Please read a message about recruiting fraud and steps you can take to protect yourself here: https://www.sarepta.com/recruiting-fraud
- Website
-
http://www.sarepta.com
External link for Sarepta Therapeutics
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, MA
- Type
- Public Company
Locations
-
Primary
215 First Street
Cambridge, MA 02142, US
-
100 Federal St
Andover, Massachusetts 01810, US
Employees at Sarepta Therapeutics
Updates
-
Today we welcomed the remainder of our 2024 summer interns. Welcome! To make sure all our interns get the most of their experience, we asked Executive Vice President and Chief People Officer Alison Nasisi, along with three former interns now full-time colleagues, what advice they have for our Class of 2024 interns. Watch below: #internship #intern
-
Pride Month is rolling on here at Sarepta. This week, members of our team enjoyed participating in the Massachusetts LGBT Chamber of Commerce, Inc. LGBTQ+ Job Fair, hosted by Suffolk University Center for Career Equity, Development & Success. For the second year in a row, we met with folks interested in learning more about Sarepta and our commitment to #DEI through employee resource groups like Sarepta Pride. Missed us there? Learn more at sarepta.com/join-us.
-
Happy #PrideMonth! In June, and all year long, we celebrate the contributions made by the LGBTQ+ community to history, society, science and beyond – especially at Sarepta. We are committed to fostering an inclusive work environment where every Sarepta team member can bring their authentic self to work. The experience of our employees is critical to achieving our mission. Sarepta Pride, our employee resource group (ERG) for LGBTQIA+ employees and allies, provides a forum in which to promote a dynamic, welcoming and educated atmosphere at Sarepta. By advancing inclusion, belonging and connection, we not only support our employees, but we also enable our ability to excel. To learn more about our ERGs, visit: https://bit.ly/458jeda #Pride2024
-
“Duchenne is not normal. It’s a rare disease. But for us, Duchenne is normal. It’s our normal. And that’s what we need it to be to keep moving forward.” At Sarepta, we’re committed to understanding the lives of people impacted by Duchenne – their normal. We’re grateful to Nick and Agnes for sharing their story and the lessons they’ve learned since Darren, their son, was diagnosed at age 2. Watch their full story: https://bit.ly/4aF9acK
-
We are excited to welcome in a new class of summer interns! Across all five of our sites, plus remote locations, our interns will support 22 different teams and take a deep dive into Sarepta’s business, research activities and culture. Our interns come from STEM and non-STEM backgrounds; some are undergraduate students, and some are pursuing advanced degrees. Each intern will have the chance for hands-on learning and the opportunity to see what it’s like working in a biotech company at the leading edge of precision genetic medicine. We’re excited to get started!
-
Are you attending CureDuchenne FUTURES and have a question for Sarepta? Our team is available throughout the conference at our two booths and our Lego activity. Hope to see you there!
-
We’re thrilled to be a Diamond sponsor CureDuchenne’s FUTURES conference on May 23-26 and look forward to connecting with families in Orlando, Florida.
-
Sarepta is a proud partner and supporter of ProFound, a professional network focused on amplifying disability leadership in the workforce. We were pleased to recently host ProFound leadership, Boston-area ProFound members and Sarepta employees to learn more about disability inclusion at work and Sarepta’s work to further embed disability into our DEI program. #Inclusion
-
We had a great time in Baltimore. Thank you to everyone who visited our booth and connected with our team at #ASGCT2024. See you next year!